LEXARIA BIOSCIENCE CORP. (LEXX)

Every figure this model derived for LEXX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-05-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 40,817 PaymentsToAcquirePropertyPlantAndEquipment 2026-05-31
cash 3,642,103 CashAndCashEquivalentsAtCarryingValue 2026-05-31
current assets 4,064,869 AssetsCurrent 2026-05-31
current liabilities 383,412 LiabilitiesCurrent 2026-05-31
equity 4,738,210 StockholdersEquity 2026-05-31
ocf -7,425,488 NetCashProvidedByUsedInOperatingActivities 2026-05-31
revenue 194,000 Revenues 2026-05-31
sbc 365,458 ShareBasedCompensation 2026-05-31

The ratios

The figures themselves rather than their scores — what somebody looking up LEXX on one particular measure came for.

RatioValue
current ratio10.6
current ratio reported10.6
deferred revenue growth-100.0
dilution pct45.38
growth cv1.71
revenue growth-68.5
revenue growth per share-78.33
roic-555.54
rule of 40-4041.66
sbc pct revenue188.38

What to be careful about

What this model itself distrusts about LEXX's figures. Written by the derivation as it ran, not added afterwards.